Trials / Not Yet Recruiting
Not Yet RecruitingNCT06510673
Extracorporeal Shock Wave Therapy Versus High Power LASER Therapy for the Treatment of Females With Calcaneal Spur
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 25 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur. HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur. RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Platelet rich plasma | Platelet-rich plasma for the heel |
| OTHER | High power LASER | High power LASER sessions for the heel |
| OTHER | Shockwave therapy | Shockwave therapy sessions for the heel |
| OTHER | Ice application | Ice application for the heel |
| OTHER | Sham LASER | Sham LASER for the heel |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-04-01
- Completion
- 2025-06-01
- First posted
- 2024-07-19
- Last updated
- 2024-08-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06510673. Inclusion in this directory is not an endorsement.